Literature DB >> 25064227

Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease.

P Ramachandran1, N P Shanmugam, S Al Sinani, V Shanmugam, S Srinivas, M Sathiyasekaran, V Tamilvanan, M Rela.   

Abstract

PURPOSE: Children with cholestatic disorders have undergone liver transplantation for intractable pruritus unresponsive to medical therapy even in the absence of liver failure. Biliary diversion procedures interrupt the entero-hepatic circulation of bile acids allowing them to be excreted in the feces thereby lowering the total bile acid pool. We evaluated the outcome of partial internal biliary diversion (PIBD) in children with intractable pruritus from inherited cholestatic disorders.
METHODS: The records of children who underwent PIBD over a 4-year period were reviewed for etiology of liver disease, demographic data, preoperative and postoperative biochemical profile and improvement of pruritus. Standard statistical methods were used for analysis.
RESULTS: Of the 12 children, 10 had progressive familial intrahepatic cholestasis (PFIC) and 2 had Alagille syndrome (AS). PIBD was done using an isolated jejunal loop as a conduit from gall bladder to mid ascending colon. Median period of follow up was 30 months. Pruritus resolved in nine children with significant reduction of serum bile acids (P < 0.02).
CONCLUSION: To our knowledge, this is the largest reported series of children with PIBD. PIBD is a safe, well-tolerated and effective alternative to liver transplant in children with PFIC and AS who have intractable pruritus in the absence of synthetic liver failure.

Entities:  

Mesh:

Year:  2014        PMID: 25064227     DOI: 10.1007/s00383-014-3559-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  19 in total

1.  Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.

Authors:  M Melter; B Rodeck; R Kardorff; P F Hoyer; C Petersen; A Ballauff; J Brodehl
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Modified laparoscopic external biliary diversion for benign recurrent intrahepatic cholestasis in obese adolescents.

Authors:  Martin L Metzelder; Claus Petersen; Michael Melter; Benno M Ure
Journal:  Pediatr Surg Int       Date:  2006-05-05       Impact factor: 1.827

Review 3.  Partial internal biliary diversion for Alagille syndrome: case report and review of the literature.

Authors:  Shari Sheflin-Findling; Ronen Arnon; Samantha Lee; Jaime Chu; Fiona Henderling; Nanda Kerkar; Kishore Iyer
Journal:  J Pediatr Surg       Date:  2012-07       Impact factor: 2.545

4.  Characteristics and outcome of liver transplantation in children with Alagille syndrome: a single-center experience.

Authors:  Chi-Ning Lee; Mao-Meng Tiao; Hung-Jen Chen; Allan Concejero; Chao-Long Chen; Ying-Hsien Huang
Journal:  Pediatr Neonatol       Date:  2013-10-08       Impact factor: 2.083

5.  Ileal exclusion in children with progressive familial intrahepatic cholestasis.

Authors:  Irena Jankowska; Piotr Czubkowski; Piotr Kaliciński; Hor Ismail; Adam Kowalski; Józef Ryżko; Joanna Pawłowska
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-01       Impact factor: 2.839

6.  Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.

Authors:  H Ismail; P Kaliciński; M Markiewicz; I Jankowska; J Pawłowska; P Kluge; E Eliadou; A Kamiński; M Szymczak; T Drewniak; Y Revillon
Journal:  Pediatr Transplant       Date:  1999-08

7.  Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis.

Authors:  P F Whitington; G L Whitington
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

8.  Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's College Hospital experience.

Authors:  Victoria Kronsten; Emer Fitzpatrick; Alastair Baker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

9.  Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.

Authors:  P J Kaliciński; H Ismail; I Jankowska; A Kamiński; J Pawłowska; T Drewniak; M Markiewicz; M Szymczak
Journal:  Eur J Pediatr Surg       Date:  2003-10       Impact factor: 2.191

10.  Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis.

Authors:  A Bassas; M Chehab; H Hebby; M Al Shahed; H Al Husseini; A Al Zahrani; S Wali
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066

View more
  14 in total

Review 1.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

2.  Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome.

Authors:  Sajan Agarwal; Bikrant Bihari Lal; Dinesh Rawat; Archana Rastogi; Kishore G S Bharathy; Seema Alam
Journal:  J Clin Exp Hepatol       Date:  2016-05-24

3.  Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.

Authors:  Kasper S Wang; Greg Tiao; Lee M Bass; Paula M Hertel; Douglas Mogul; Nanda Kerkar; Matthew Clifton; Colleen Azen; Laura Bull; Philip Rosenthal; Dylan Stewart; Riccardo Superina; Ronen Arnon; Molly Bozic; Mary L Brandt; Patrick A Dillon; Annie Fecteau; Kishore Iyer; Binita Kamath; Saul Karpen; Frederick Karrer; Kathleen M Loomes; Cara Mack; Peter Mattei; Alexander Miethke; Kyle Soltys; Yumirle P Turmelle; Karen West; Jessica Zagory; Cat Goodhue; Benjamin L Shneider
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

4.  Nasobiliary drainage: an effective treatment for pruritus in cholestatic liver disease.

Authors:  Wafaa Ahmed; Rebecca Jeyaraj; David Reffitt; John Devlin; Abid Suddle; John Hunt; Michael A Heneghan; Phillip Harrison; Deepak Joshi
Journal:  Frontline Gastroenterol       Date:  2022-01-11

5.  Nasobiliary drainage prior to surgical biliary diversion in progressive familial intrahepatic cholestasis type II.

Authors:  Giulia Jannone; Xavier Stephenne; Isabelle Scheers; Françoise Smets; Catherine de Magnée; Raymond Reding; Etienne M Sokal
Journal:  Eur J Pediatr       Date:  2020-04-14       Impact factor: 3.183

6.  Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients.

Authors:  Hamid Reza Foroutan; Ali Bahador; Sultan Mohsin Ghanim; Seyed Mohsen Dehghani; Mohammad Hossein Anbardar; Mohammad Reza Fattahi; Mehdi Forooghi; Omidreza Azh; Ali Tadayon; Alireza Sherafat; Amir Arsalan Yaghoobi; Mohammad Ali Ashraf
Journal:  Pediatr Surg Int       Date:  2020-03-23       Impact factor: 1.827

Review 7.  Current and future therapies for inherited cholestatic liver diseases.

Authors:  Wendy L van der Woerd; Roderick Hj Houwen; Stan Fj van de Graaf
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

8.  Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis.

Authors:  Anjali Sharma; Ujjal Poddar; Shikha Agnihotry; Shubha R Phadke; Surender K Yachha; Rakesh Aggarwal
Journal:  BMC Gastroenterol       Date:  2018-07-04       Impact factor: 3.067

Review 9.  Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment.

Authors:  Mithat Gunaydin; Asudan Tugce Bozkurter Cil
Journal:  Hepat Med       Date:  2018-09-10

10.  Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.

Authors:  Deng Xiang; Jiannan He; Hongmei Wang; Fangfang Xiong; Hao Cheng; Junhua Ai; Renfeng Shan; Renhua Wan; Lunli Zhang; Jun Shi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.